ATE35546T1 - 1-(substituiertes aryl)-dihydro-1h-pyrrolizin-3,5-(2h,6h>dione, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzung. - Google Patents

1-(substituiertes aryl)-dihydro-1h-pyrrolizin-3,5-(2h,6h>dione, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzung.

Info

Publication number
ATE35546T1
ATE35546T1 AT85302948T AT85302948T ATE35546T1 AT E35546 T1 ATE35546 T1 AT E35546T1 AT 85302948 T AT85302948 T AT 85302948T AT 85302948 T AT85302948 T AT 85302948T AT E35546 T1 ATE35546 T1 AT E35546T1
Authority
AT
Austria
Prior art keywords
compounds
pyrrolizine
dihydro
dione
preparation
Prior art date
Application number
AT85302948T
Other languages
English (en)
Inventor
Donald E Butler
Anthony J Thomas
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE35546T1 publication Critical patent/ATE35546T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/50Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C205/53Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT85302948T 1984-05-07 1985-04-26 1-(substituiertes aryl)-dihydro-1h-pyrrolizin-3,5-(2h,6h>dione, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzung. ATE35546T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/607,375 US4548947A (en) 1984-05-07 1984-05-07 1-(Substituted-aryl)-dihydro-1H-pyrrolizine-3,5-[2H,6H-]diones and use for reversing amnesia
EP85302948A EP0164852B1 (de) 1984-05-07 1985-04-26 1-(Substituiertes Aryl)-dihydro-1H-pyrrolizin-3,5-[2H,6H]dione, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende pharmazeutische Zusammensetzung

Publications (1)

Publication Number Publication Date
ATE35546T1 true ATE35546T1 (de) 1988-07-15

Family

ID=24431993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85302948T ATE35546T1 (de) 1984-05-07 1985-04-26 1-(substituiertes aryl)-dihydro-1h-pyrrolizin-3,5-(2h,6h>dione, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzung.

Country Status (10)

Country Link
US (1) US4548947A (de)
EP (1) EP0164852B1 (de)
JP (1) JPS60239487A (de)
AT (1) ATE35546T1 (de)
AU (1) AU564866B2 (de)
CA (1) CA1252105A (de)
DE (1) DE3563626D1 (de)
DK (1) DK201585A (de)
ES (1) ES8609326A1 (de)
ZA (1) ZA852874B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663464A (en) * 1986-03-21 1987-05-05 Warner-Lambert Company Process for the preparation of dihydro-1H-pyrrolizine-3,5-(2H,6H)-dione
CN107188808A (zh) * 2017-05-22 2017-09-22 江苏斯威森生物医药工程研究中心有限公司 一种4‑氨基‑3‑苯基丁酸盐酸盐的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1350582A (en) * 1970-07-24 1974-04-18 Ucb Sa Cerivatives of 2-pyrrolidinone
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
US4372966A (en) * 1980-09-15 1983-02-08 Warner-Lambert Company Use of dihydro-1H-pyrrolizine-3,5(2H,6H)-dione as a cognition activator
US4547519A (en) * 1982-05-24 1985-10-15 Warner-Lambert Company Tetrahydro-3,5-dioxo-1H-pyrrolizine-7a(5H)-carboxylic acid and benzyl esters and amides thereof and their use in reversing amnesia

Also Published As

Publication number Publication date
EP0164852B1 (de) 1988-07-06
JPS60239487A (ja) 1985-11-28
EP0164852A1 (de) 1985-12-18
ES8609326A1 (es) 1986-07-16
AU4134085A (en) 1985-11-14
AU564866B2 (en) 1987-08-27
DK201585D0 (da) 1985-05-06
DE3563626D1 (en) 1988-08-11
US4548947A (en) 1985-10-22
ZA852874B (en) 1986-11-26
ES542810A0 (es) 1986-07-16
CA1252105A (en) 1989-04-04
DK201585A (da) 1985-11-08

Similar Documents

Publication Publication Date Title
DE69325662D1 (de) Dopamin rezeptor subtyp liganden
IL66341A (en) Pyrrolidin-2-oxo-1-acetamides,their manufacture and pharmaceutical compositions containing them
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
ATE161717T1 (de) Antivirale mittel
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
PT77990B (en) Process for the preparation of new benzoylurea compounds and of compositions containing same being some of them active in the control of mites whitefly and thrips and others pharmaceutical ones destined to combat tumors in living beings as well as for the utilization of same
ATE35546T1 (de) 1-(substituiertes aryl)-dihydro-1h-pyrrolizin-3,5-(2h,6h>dione, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzung.
ATE42292T1 (de) Imidazo(1,2-c)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
MD1687F2 (en) Arylthiocompounds, pharmaceutical composition, methods of bacterial and viral infections treatment
ES8203870A1 (es) Procedimiento para preparar difenilbutil-1-acilpiperazinas
ES8600224A1 (es) Procedimiento de preparacion de nuevos derivados carbamiloxibenzoles
DE59107813D1 (de) Alkylaminoalkylamin- und -äther- Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2707984B1 (fr) Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
ATE35538T1 (de) (substituierte phenyl)-5-oxo-2pyrrolidinpropions|uren, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
IL83164A (en) Pharmaceutical compositions containing 2,3-dihydro-5-(hetero)aryl-imidazo(2,1-a)isoquinolines,some new such compounds and their preparation
ATE34740T1 (de) (bis(hydroxymethyl)methyl)-isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ES8403891A1 (es) Un procedimiento para la preparacion de un derivado del acido furiloxazolila-cetico
ATE3977T1 (de) Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE30712T1 (de) 4-hydroxy-alpha-aethyl-benzhydrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
SE8701524D0 (sv) Nya sulfonamider och deras framstellningsforfarande
ES479804A1 (es) Un procedimiento para la preparacion de derivados del acido amino-desoxi-clavulanico.
ES8506700A1 (es) Un procedimiento para preparar nuevas 5-aminometil-imidazol-1-il-1,3-dialquil-1h-pirazol-4-il-aroil-metanonas
TH4614EX (th) อนุพันธ์ของไธอะซิโนน

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee